Liqun Li

Prof. Dr. Liqun Li

orcid

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 February 2025 in Cell Proliferation
Verified
Journal Article
Open access
SongYun ZhaoSongYun Zhao
SongYun Zhao
JXJiaheng Xie
Jiaheng Xie
QZQian Zhang
Qian Zhang
TNTianyi Ni
Tianyi Ni
JLJinde Lin
Jinde Lin
WYWei Yan
Wei Yan
Keloids are complex pathological skin scars characterised by excessive growth of fibrous tissue and abnormal accumulation of extracellular matrix (ECM). Despite various treatment options available, the treatment of keloids remains a major clinical challenge due to high recurrence rates and inconsistent therapeutic outcomes. By collecting three keloid tissues and three normal skin samples and utilising single‐cell RNA sequencing (scRNA‐seq), we delved into the cellular heterogeneity and molecular mechanisms of keloids. Our study identified multiple fibroblast subpopulations within keloid tissue. Enrichment and cell–cell communication analyses revealed that POSTN‐positive mesenchymal fibroblasts (POSTN+ mesenchymal fibs) are more prevalent in keloids and exhibit higher transforming growth factor β (TGF‐β) signalling activity, potentially playing a central role in excessive fibrosis. In contrast, IGFBP2‐positive fibroblasts (IGFBP2+ fibs) are more abundant in normal skin, insensitive to TGF‐β and Periostin signalling, and possess anti‐fibrotic potential, possibly related to limited tissue repair and regenerative capacity. Trajectory analysis inferred the differentiation states and patterns of different fibroblast subpopulations. Additionally, we explored the heterogeneity of endothelial cells, finding an endothelial cell subpopulation (EC10) exhibiting mesenchymal activation characteristics, which may work with specific fibroblasts to promote abnormal angiogenesis and endothelial‐to‐mesenchymal transition processes. Spatial transcriptomics analysis has shown that the proportion of IGFBP2+ fibroblasts relatively increases in acne keloidalis after hormonal treatment, further demonstrating their value as potential therapeutic targets. Ultimately, we separated these two subpopulations using flow cytometry, highlighting their opposing roles in the secretion of the ECM. These findings provide new insights into the pathogenesis of keloids and lay the theoretical foundation for the development of innovative anti‐fibrotic treatment strategies.

22 March 2025 in Biology Direct
Verified
Journal Article
Open access
PDF file
SZSongyun Zhao
Songyun Zhao
HYHua Yu
Hua Yu
ZLZihao Li
Zihao Li
WCWanying Chen
Wanying Chen
KLKaibo Liu
Kaibo Liu
LLLiqun Li
Liqun Li
Diabetic foot ulcers (DFU) are a common and severe complication among diabetic patients, posing a significant burden on patients’ quality of life and healthcare systems due to their high incidence, amputation rates, and mortality. This study utilized single-cell RNA sequencing technology to deeply analyze the cellular heterogeneity of the skin on the feet ofDFU patients and the transcriptomic characteristics of endothelial cells, aiming to identify key cell populations and genes associated with the healing and progression of DFU. The study found that endothelial cells from DFU patients exhibited significant transcriptomic differences under various conditions, particularly in signaling pathways related to inflammatory responses and angiogenesis. Through trajectory analysis and cell communication research, we revealed the key role of endothelial cell subsets in the development of DFU and identified multiple important gene modules associated with the progression of DFU. Notably, the promoting effect of the SH3BGRL3 gene on endothelial cell proliferation, migration, and angiogenic capabilities under high glucose conditions was experimentally verified, providing a new potential target and theoretical basis for the treatment of DFU. This study not only enhances the understanding of the pathogenesis ofDFU but also provides a scientific basis for the development ofnew therapeutic strategies.

7 April 2025 in BMC Cancer
Verified
Journal Article
Open access
PDF file
SZSongyun Zhao
Songyun Zhao
ZLZihao Li
Zihao Li
KLKaibo Liu
Kaibo Liu
GWGaoyi Wang
Gaoyi Wang
QWQuanqiang Wang
Quanqiang Wang
LLLiqun Li
Liqun Li
Melanoma (SKCM) is an extremely aggressive form of cancer, characterized by high mortality rates, frequent metastasis, and limited treatment options. Our study aims to identify key target genes and enhance the diagnostic accuracy of melanoma prognosis by employing multi-omics analysis and machine learning techniques, ultimately leading to the development of novel therapeutic strategies. We obtained and processed transcriptomic data, including RNA expression profiles, methylation microarray data, gene mutation data, and clinical information, from the TCGA dataset using multi-omics analysis and machine learning techniques. We comprehensively evaluated the molecular subtypes of melanoma, the characteristics of the tumor microenvironment (TME), and their effects on patient outcomes. By analyzing the TCGA-SKCM and GEO cohorts, we identified three melanoma subtypes with distinct prognostic features. Additionally, we developed a machine learning-driven signature (MLDS) based on marker genes for different molecular subtypes to significantly improve the prognostic prediction accuracy for melanoma patients. We also extensively examined differences in clinical features, immune cell infiltration, mutational landscapes, and drug treatment effects between high- and low-scoring subgroups. The predictive reliability of MLDS was further explored by knocking down the key signature gene AGPAT2 in melanoma cells using small interfering RNA. The MLDS demonstrated high C-index values in both the training and validation cohorts, indicating its potential for clinical decision-making. The study also found that MLDS scores were associated with reduced immune cell infiltration and lower expression levels of immune checkpoints. Patients in the low MLDS group may be more responsive to chemotherapeutic agents and more likely to benefit from immune checkpoint inhibitors (ICIs). Single-cell sequencing analysis revealed that the MAPK signaling pathway between AGPAT2 + melanoma cells and fibroblasts/myeloid cells promotes tumor survival in the TME. Finally, the oncogenic role of AGPAT2 in melanoma cell lines was successfully confirmed through cell function assays and subcutaneous tumor formation assays in nude mice. This study not only uncovers the diversity and complexity of melanoma molecular subtypes but also underscores the crucial role of the TME in melanoma progression. It provides new insights and tools for personalized treatment and prognostic assessment of SKCM.

26 September 2025 in Apoptosis
Verified
Journal Article
Closed access
PDF file
SZSongyun Zhao
Songyun Zhao
XLXiaoqing Liang
Xiaoqing Liang
JXJiaheng Xie
Jiaheng Xie
ZLZijian Lin
Zijian Lin
ZLZihao Li
Zihao Li
LLLiqun Li
Liqun Li

19 April 2025 in Materials Today Bio
Verified
Journal Article
Closed access
HYHua Yu
Hua Yu
BWBin Wang
Bin Wang
ZLZihao Li
Zihao Li
KLKaibo Liu
Kaibo Liu
WCWanying Chen
Wanying Chen
LLLiqun Li
Liqun Li

25 April 2026 in The FASEB Journal
Verified
Journal Article
Open access
SongYun ZhaoSongYun Zhao
SongYun Zhao
WCWanying Chen
Wanying Chen
KLKaibo Liu
Kaibo Liu
JXJiaheng Xie
Jiaheng Xie
YCYanming Chen
Yanming Chen
LLLiqun Li
Liqun Li
Diabetic wounds, particularly diabetic foot ulcers, represent a significant clinical challenge owing to impaired vascularization, persistent inflammation, and dysfunctional extracellular matrix remodeling. Although adipose‐derived stem cells offer therapeutic potential, their heterogeneity and functional impairment within the diabetic microenvironment limit their efficacy. Using single‐cell RNA sequencing of human adipose and diabetic wound tissues, we identified a distinct CCL2‐expressing ADSC subpopulation that is enriched in obese individuals and exhibits elevated stemness, unique metabolic profiles, and enrichment in pathways related to ECM organization and tissue development. This subpopulation functions as a key communication node, engaging with fibroblasts, macrophages, and endothelial cells through ligand–receptor interactions such as CCL2‐ACKR1, TGFB1‐TGFBR1, and IL34‐CSF1R. Exosomes secreted by these CCL2‐positive ADSCs were found to be enriched in CCL2, TGFB1, and IL34. In a diabetic mouse wound model, CCL2‐ADSC‐derived exosomes significantly accelerated wound closure compared with conventional exosomes, promoting angiogenesis, collagen deposition, and M2‐macrophage polarization while reducing pro‐inflammatory cytokines. In vitro, these exosomes reversed high‐glucose‐induced suppression of endothelial cell proliferation, migration, and tube formation. Mechanistically, CCL2 carried by the exosomes activates the PI3K/AKT/mTOR/HIF‐1α signaling axis in endothelial cells via ACKR1, an effect abolished by CCL2 neutralization or ACKR1 knockdown. Together, these results demonstrate that the CCL2‐positive ADSC subpopulation exerts multi‐cellular and multi‐target therapeutic actions, and that exosomes derived from this subpopulation offer a potent cell‐free strategy to enhance diabetic wound healing by improving vascularization, modulating immune responses, and supporting ECM remodeling.